Skip to content
Screener

Baxter International BAX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$3.9M+77.3%
Axogen logo
AxogenAXGN
$134.04M
ICU Medical logo
ICU MedicalICUI
$490K-91.6%
Omnicell logo
OmnicellOMCL
$97K
LeMaitre Vascular logo
LeMaitre VascularLMAT
$776K-55.9%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$184K+15.7%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Repayments of debt(2,825)
Repayments of debt with original maturities of three months or less(300)
Cash dividends on common stock(5)(87)
Proceeds from stock issued under employee benefit plans810
Other financing activities, net(14)(24)
Cash flows from (used in) financing activities(11)(3,226)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash - continuing operations(18)36
Increase (decrease) in cash, cash equivalents and restricted cash51(118)

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's stock issuance proceeds?
Baxter International (BAX) reported stock issuance proceeds of $8M in Q1 2026.
How has Baxter International's stock issuance proceeds changed year-over-year?
Baxter International's stock issuance proceeds decreased by 20.0% year-over-year, from $10M to $8M.
What is the long-term trend for Baxter International's stock issuance proceeds?
Over 4 years (2021 to 2025), Baxter International's stock issuance proceeds has grown at a -36.7% compound annual growth rate (CAGR), from $187M to $30M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Ask your AI about Baxter International's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude